Literature DB >> 20483783

HLA-F complex without peptide binds to MHC class I protein in the open conformer form.

Jodie P Goodridge1, Aura Burian, Ni Lee, Daniel E Geraghty.   

Abstract

HLA-F has low levels of polymorphism in humans and is highly conserved among primates, suggesting a conserved function in the immune response. In this study, we probed the structure of HLA-F on the surface of B lymphoblastoid cell lines and activated lymphocytes by direct measurement of peptide binding to native HLA-F. Our findings suggested that HLA-F is expressed independently of bound peptide, at least in regard to peptide complexity profiles similar to those of either HLA-E or classical MHC class I (MHC-I). As a further probe of native HLA-F structure, we used a number of complementary approaches to explore the interactions of HLA-F with other molecules, at the cell surface, intracellularly, and in direct physical biochemical measurements. This analysis demonstrated that HLA-F surface expression was coincident with MHC-I H chain (HC) expression and was downregulated upon perturbation of MHC-I HC structure. It was further possible to directly demonstrate that MHC-I would interact with HLA-F only when in the form of an open conformer free of peptide and not as a trimeric complex. This interaction was directly observed by coimmunoprecipitation and by surface plasmon resonance and indirectly on the surface of cells through coincident tetramer and MHC-I HC colocalization. These data suggest that HLA-F is expressed independently of peptide and that a physical interaction specific to MHC-I HC plays a role in the function of MHC-I HC expression in activated lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483783      PMCID: PMC3777411          DOI: 10.4049/jimmunol.1000078

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern.

Authors:  S D Wainwright; P A Biro; C H Holmes
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules.

Authors:  Nilabh Shastri; Susan Schwab; Thomas Serwold
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  Misfolding of major histocompatibility complex class I molecules in activated T cells allows cis-interactions with receptors and signaling molecules and is associated with tyrosine phosphorylation.

Authors:  Susana G Santos; Simon J Powis; Fernando A Arosa
Journal:  J Biol Chem       Date:  2004-10-07       Impact factor: 5.157

Review 4.  Tails of wonder: endocytic-sorting motifs key for exogenous antigen presentation.

Authors:  Gregory Lizée; Genc Basha; Wilfred A Jefferies
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

Review 5.  Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G.

Authors:  C A O'Callaghan; J I Bell
Journal:  Immunol Rev       Date:  1998-06       Impact factor: 12.988

6.  Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E.

Authors:  C A O'Callaghan; J Tormo; B E Willcox; V M Braud; B K Jakobsen; D I Stuart; A J McMichael; J I Bell; E Y Jones
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

7.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

Authors:  S Bauer; V Groh; J Wu; A Steinle; J H Phillips; L L Lanier; T Spies
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

8.  Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection.

Authors:  J N Blattman; D J Sourdive; K Murali-Krishna; R Ahmed; J D Altman
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

9.  The mouse CD1d cytoplasmic tail mediates CD1d trafficking and antigen presentation by adaptor protein 3-dependent and -independent mechanisms.

Authors:  Anna P Lawton; Theodore I Prigozy; Laurent Brossay; Bo Pei; Archana Khurana; Donald Martin; Tiancheng Zhu; Kira Späte; Megda Ozga; Stefan Höning; Oddmund Bakke; Mitchell Kronenberg
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

10.  Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors.

Authors:  E J Lepin; J M Bastin; D S Allan; G Roncador; V M Braud; D Y Mason; P A van der Merwe; A J McMichael; J I Bell; S H Powis; C A O'Callaghan
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

View more
  35 in total

1.  Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.

Authors:  Charles L Dulberger; Curtis P McMurtrey; Angelique Hölzemer; Karlynn E Neu; Victor Liu; Adriana M Steinbach; Wilfredo F Garcia-Beltran; Michael Sulak; Bana Jabri; Vincent J Lynch; Marcus Altfeld; William H Hildebrand; Erin J Adams
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

Review 2.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.

Authors:  Peter Parham; Paul J Norman; Laurent Abi-Rached; Lisbeth A Guethlein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

3.  HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.

Authors:  Jodie P Goodridge; Ni Lee; Aura Burian; Chul-Woo Pyo; Scott S Tykodi; Edus H Warren; Cassian Yee; Stanley R Riddell; Daniel E Geraghty
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

4.  KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease.

Authors:  Harry Petrushkin; Paul J Norman; Emma Lougee; Peter Parham; Graham R Wallace; Miles R Stanford; Farida Fortune
Journal:  J Immunol       Date:  2019-08-12       Impact factor: 5.422

5.  A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.

Authors:  Elena Lorente; Susana Infantes; David Abia; Eilon Barnea; Ilan Beer; Ruth García; Fátima Lasala; Mercedes Jiménez; Carmen Mir; Antonio Morreale; Arie Admon; Daniel López
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

6.  HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.

Authors:  Jodie P Goodridge; Aura Burian; Ni Lee; Daniel E Geraghty
Journal:  J Immunol       Date:  2013-09-09       Impact factor: 5.422

7.  α3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells.

Authors:  Xi-He Zhang; Xiao-Dong Lian; Zheng-Xi Dai; Hong-Yi Zheng; Xin Chen; Yong-Tang Zheng
Journal:  J Immunol       Date:  2017-08-07       Impact factor: 5.422

8.  A Distinctive Cytoplasmic Tail Contributes to Low Surface Expression and Intracellular Retention of the Patr-AL MHC Class I Molecule.

Authors:  Ana Goyos; Lisbeth A Guethlein; Amir Horowitz; Hugo G Hilton; Michael Gleimer; Frances M Brodsky; Peter Parham
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

9.  HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1.

Authors:  Zahra Kiani; Julie Bruneau; Daniel E Geraghty; Nicole F Bernard
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

Review 10.  Structural insights into activation of antiviral NK cell responses.

Authors:  Kathryn A Finton; Roland K Strong
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.